NMR-based metabolomics in real-time monitoring of treatment induced toxicity and cachexia in head and neck cancer: a method for early detection of high risk patients-Reference-Cited by-同舟云学术

NMR-based metabolomics in real-time monitoring of treatment induced toxicity and cachexia in head and neck cancer: a method for early detection of high risk patients

Published:2019-08 Issue:8 Volume:15 Page:
ISSN:1573-3882
Container-title:Metabolomics
language:en
Short-container-title:Metabolomics

Author:

Boguszewicz Ł.^ORCID,Bieleń A.,Mrochem-Kwarciak J.,Skorupa A.,Ciszek M.,Heyda A.,Wygoda A.,Kotylak A.,Składowski K.,Sokół M.

Funder

Narodowe Centrum Nauki

Publisher

Springer Science and Business Media LLC

Subject

Clinical Biochemistry,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s11306-019-1576-4.pdf

Reference63 articles.

1. Abd Rahman, S., Schirra, H. J., Lichanska, A. M., Huynh, T., & Leong, G. M. (2013). Urine metabonomic profiling of a female adolescent with PIT-1 mutation before and during growth hormone therapy: Insights into the metabolic effects of growth hormone. Growth Hormone & IGF Research, 23(1–2), 29–36. https://doi.org/10.1016/j.ghir.2012.12.001 .

2. Aoyagi, T., Terracina, K. P., Raza, A., Matsubara, H., & Takabe, K. (2015). Cancer cachexia, mechanism and treatment. World Journal of Gastrointestinal Oncology, 7, 17–29. https://doi.org/10.4251/wjgo.v7.i4.17 .

3. Aversa, Z., Costelli, P., & Muscaritoli, M. (2017). Cancer-induced muscle wasting: Latest findings in prevention and treatment. Therapeutic Advances in Medical Oncology, 9(5), 369–382. https://doi.org/10.1177/1758834017698643 .

4. Bae, H. R., Kim, D. H., Park, M. H., Lee, B., Kim, M. J., Lee, E. K., et al. (2016). β-Hydroxybutyrate suppresses inflammasome formation by ameliorating endoplasmic reticulum stress via AMPK activation. Oncotarget, 7(41), 66444. https://doi.org/10.18632/oncotarget.12119 .

5. Bartmann, C., Raman, S. R. J., Flöter, J., Schulze, A., Bahlke, K., Willingstorfer, J., et al. (2018). Beta-hydroxybutyrate (3-OHB) can influence the energetic phenotype of breast cancer cells, but does not impact their proliferation and the response to chemotherapy or radiation. Cancer & Metabolism, 6(1), 8. https://doi.org/10.1186/s40170-018-0180-9 .

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The performance of metabolomics-based prediction scores for mortality in older patients with solid tumors;GeroScience;2024-07-04

2. Metabolite Biomarkers of Prolonged and Intensified Pain and Distress in Head and Neck Cancer Patients Undergoing Radio- or Chemoradiotherapy by Means of NMR-Based Metabolomics—A Preliminary Study;Metabolites;2024-01-17

3. Human Urinary Metabolomics as Biomarkers in Tobacco Users: A Systematic Review;Contemporary Clinical Dentistry;2024-01

4. Metabolomic Insight into Implications of Induction Chemotherapy Followed by Concomitant Chemoradiotherapy in Locally Advanced Head and Neck Cancer;International Journal of Molecular Sciences;2023-12-22

5. Effect of Regular Consumption of a Miraculin-Based Food Supplement on Taste Perception and Nutritional Status in Malnourished Cancer Patients: A Triple-Blind, Randomized, Placebo-Controlled Clinical Trial-CLINMIR Pilot Protocol;Nutrients;2023-11-01